Haploidentical natural killer cell infusion

· St. Jude Children's Research Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Haploidentical natural killer cell infusion, covering 2013-07-16 to 2013-07-16. Get the full timeline:

Most recent: Clinical Trial Update: Pilot Study of Haploidentical Natural Killer Cell Infusions for Poor Prognosis Non-AML Hematologic Malignancies [Phase 1]

See pricing